Muscle fibers in children with SMA type 1 show substantial differences in components of the myosin protein called heavy ...

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.

10月29日，南方医院心血管内科修建成团队成功应用国产肾神经标测/选择性消融系统为一例难治性高血压和一例药物不耐受高血压患者施行经肾动脉去肾交感神经术 (renal ...

The U.S. Medicare outpatient final rule affirms several new devices for the new technology pass-through program, but one of the more significant findings is that CMS will use separate payment ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the ...

GALWAY, Ireland, Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

On October 29, DeepQure announced its participation in TCT 2024 (Transcatheter Cardiovascular Therapeutics), held in Washington, D.C. TCT is one of the world's premier forums for interventional ...

The two-year data aligns with previous long-term results, showcasing meaningful and enduring blood pressure decreases.